Advances in transformable drug delivery systems

Biomaterials. 2018 Sep:178:546-558. doi: 10.1016/j.biomaterials.2018.03.056. Epub 2018 Apr 5.

Abstract

These years, transformable drug delivery systems (DDSs), which hold the capability of changing formulation morphology and subsequent functionality at the desired disease site, have shown great promise in control of spatio-temporal drug delivery/release manner and enhanced treatment efficacy. Equipped with controllability and design flexibility, the transformable DDSs are being increasingly pursued for the development of precision drug delivery platforms for biomedical applications. In this review, we describe the recently developed intracelluarly and extracellularly transformable DDSs, especially associated with assembly or disassociation of the original formulation units, for achieving various functionalities, including prolonged retention time, inhibited endocytosis and enhanced cytotoxicity. Furthermore, the different stimuli, such as pH, enzyme, light, temperature, redox and mechanical force that trigger the transformation process are also introduced. The future outlook and challenges are discussed in the end.

Keywords: Cancer therapy; Drug delivery; Stimuli-responsive; Transformable formulation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Drug Delivery Systems / methods*
  • Extracellular Space / chemistry
  • Humans
  • Intracellular Space / chemistry
  • Microbubbles
  • Nanoparticles / chemistry
  • Nanoparticles / ultrastructure
  • Neoplasms / diagnosis
  • Neoplasms / pathology